News/ News/ Oncology Epizyme’s sarcoma drug tazemetostat faces key vote from FDA advisers Richard Staines fda, regulation, sarcoma 0 Comment Epizyme’s sarcoma drug tazemetostat is set to go before an influential FDA advisory committee today, following a mixed Share X Epizyme’s sarcoma drug tazemetostat faces key vote from FDA advisers https://pharmaphorum.com/news/epizymes-sarcoma-drug-tazemetostat-faces-key-vote-from-fda-advisers/
